| 000 | 01758 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516091432.0 | ||
| 264 | 0 | _c20121011 | |
| 008 | 201210s 0 0 eng d | ||
| 022 | _a1365-2036 | ||
| 024 | 7 |
_a10.1111/j.1365-2036.2012.05118.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMusumba, C | |
| 245 | 0 | 0 |
_aThe relative contribution of NSAIDs and Helicobacter pylori to the aetiology of endoscopically-diagnosed peptic ulcer disease: observations from a tertiary referral hospital in the UK between 2005 and 2010. _h[electronic resource] |
| 260 |
_bAlimentary pharmacology & therapeutics _cJul 2012 |
||
| 300 |
_a48-56 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents, Non-Steroidal _xadverse effects |
| 650 | 0 | 4 |
_aAspirin _xadverse effects |
| 650 | 0 | 4 | _aEndoscopy |
| 650 | 0 | 4 | _aEndoscopy, Gastrointestinal |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHelicobacter Infections _xchemically induced |
| 650 | 0 | 4 |
_aHelicobacter pylori _xisolation & purification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPeptic Ulcer _xchemically induced |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aUnited Kingdom _xepidemiology |
| 700 | 1 | _aJorgensen, A | |
| 700 | 1 | _aSutton, L | |
| 700 | 1 | _aVan Eker, D | |
| 700 | 1 | _aMoorcroft, J | |
| 700 | 1 | _aHopkins, M | |
| 700 | 1 | _aPritchard, D M | |
| 700 | 1 | _aPirmohamed, M | |
| 773 | 0 |
_tAlimentary pharmacology & therapeutics _gvol. 36 _gno. 1 _gp. 48-56 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2036.2012.05118.x _zAvailable from publisher's website |
| 999 |
_c21751091 _d21751091 |
||